Abstract: A device for treating a liquid comprising a solvent and a solute, and separating the solvent and solute, the device comprising a continuous flow treatment chamber including: (a) one or more drying zones; (b) one or more return zones to circulate heating fluid continuously through drying zone(s) and return zone(s) sequentially; (c) a heating fluid inlet(s) in at least one of the return zones for the introduction of the heating fluid; (d) a circulating fan to circulate the heating fluid; (e) a liquid inlet(s) in the drying zone(s) including nozzles though which liquid to be treated is introduced in misted form into the zones; (f) a solute collector(s) located in the drying zone(s) downstream of the liquid inlet(s); wherein the introduced liquid is heated by the heating fluid and the solute is separated from the liquid in the solute collector(s).

Abstract: A device for treating a liquid comprising a solvent and a solute, and separating the solvent and solute, the device comprising a continuous flow treatment chamber including: (a) one or more drying zones; (b) one or more return zones to circulate heating fluid continuously through drying zone(s) and return zone(s) sequentially; (c) a heating fluid inlet(s) in at least one of the return zones for the introduction of the heating fluid; (d) a circulating fan to circulate the heating fluid; (e) a liquid inlet(s) in the drying zone(s) including nozzles though which liquid to be treated is introduced in misted form into the zones; (f) a solute collector(s) located in the drying zone(s) downstream of the liquid inlet(s); wherein the introduced liquid is heated by the heating fluid and the solute is separated from the liquid in the solute collector(s).

Abstract: A buccal delivery system capable of being blended in a normal dry powder process and compressed using a standard tabletting machine, said buccal delivery system comprising a matrix of: (a) an effective amount of one or more active ingredients; (b) an amount of one or more polyethylene glycols or derivatives thereof having a molecular weight between 1000 to 8000 sufficient to provide the required hardness and time for dissolution of the matrix; (c) 0.05-2% by weight of the total matrix of one or more suspending agents; (d) 0.05-2% by weight of the total matrix of one or more flowing agents; and (e) 0.05-2% by weight of the total matrix of one or more sweeteners.